INTRODUCTION
RNA sequencing workflows comprise of RNA purification, library generation, the sequencing itself, and the evaluation of the sequenced fragments (Wang et al. 2009 ). The first steps impose numerous, whether or not intended, biases towards RNA classes and sequence characteristics, which data processing algorithms try to compensate for afterwards (Li et al. 2010; van Dijk et al. 2014; Zheng et al. 2011) . Here, key tasks are the concordant assignment of fragments to the transcript variants, and the subsequent deduction of the corresponding abundance values. As long as the quality of all individual processing steps cannot be unequivocally determined, subsequent comparisons of experimental data, in particular but not exclusively between different data sets, remain ambiguous.
The proliferation of different RNA-Seq platforms and protocols has created the need for multi-functional spiked-in controls, which are processed alongside real samples to enable the monitoring and comparing of key performance parameters like the ability to correctly distinguish and quantify transcript variants (Fed. Reg. Doc. 2015-19742) .
At present comparisons are carried out only in exemplary inter-laboratory studies on reference RNA samples which investigate different RNA treatments, NGS platforms and data evaluation algorithms (SEQC/MAQC-III Consortium 2014; Li et al. 2014) . For these studies reference RNA samples were created from Universal Human Reference RNA (UHRR from Agilent) and Human Brain Reference RNA (HBRR from Ambion, Thermo Fisher), which contain a stable but largely unknown transcript variant diversity. In addition, the reference samples contained also a set of 92 invitro transcripts, IVTs, as spike-in controls which were developed by the External RNA Controls Consortium (Baker et al. 2005) . These control transcripts, ERCCs (Ambion, Thermo Fisher), allow to asses dynamic range, dose response, lower limit of detection, and fold-change response of RNA sequencing pipelines within the limitation of the mono-exonic, single-isoform RNA sequences (Jiang et al. 2011) . Because the ERCCs contain no transcript variants, one of the main challenges of sequencing complex transcriptomes -to identify and distinguish splice variants -could not be evaluated until now.
Here we describe the sequence design and preparation of a comprehensive and novel set of Spike-In Transcript Variants, SIRVs, and show in first examples how mixes thereof can be used to validate isoform-specific RNA sequencing workflows. Further, we demonstrate how to utilize SIRVs for comparing experiments by extrapolating the results from the well-defined ground truth of a small fraction of control reads to the sample reads. Although the focus of the first SIRV module is clearly on the resolution of transcript variants the aim is to build a modular system of IVT controls which retain in the most condensed manner all relevant aspects of the transcriptome complexity to establish a continuous referencing method for RNA sequencing experiments. Then, those controls will provide the base for lasting comparisons of the wealth of RNA-Seq data especially in the face of the rapid development of sequencing technologies.
RESULTS

SIRVS DESIGN
The SIRVs were modelled on 7 human genes, whose annotated transcripts were extended by exemplary isoforms to yield between 6 and 18 transcript variants for each gene, and 69 transcripts in total (general design overview in Suppl. Fig. S1 ). They comprehensively address start-and end-site variations, alternative splicing, overlapping genes, and antisense transcription. Fig.   1A illustrates how the human gene KLK5 served as a blue print for the design of the gene SIRV1 with its 8 transcript variants (gene structures of SIRV2 to SIRV7 are shown in the odd-numbered suppl.
Figures from S5 to S15). The SIRV genes model in a condensed and redundant manner all currently known transcription and alternative splicing variations (summary in Fig. 1B ). The transcripts range in length from 191 to 2·528 nt ( , ̅ 1·134 nt; ̃, 813 nt), and contain an additional 30 nt long poly(A)-tail.
The GC-content varies between 29.5 and 51.2 % ( ̅ , 43.0 %; ̃, 43.6 %). The exon sequences were created from a pool of database-derived genomes and modified by inverting the sequence to lose identity while maintaining a naturally occurring order in the sequences. The splice junctions conform to 96.9 % to the canonical GT-AG exon-intron junction rule with few exceptions harboring the less frequently occurring variations GC-AG (1.7 %) and AT-AC (0.6 %). Two non-canonical splice sites, CT-AG and CT-AC, account for 0.4 % each. The exon sequences were blasted against the entire NCBI database on the nucleotide and on the protein level and mapped using in silico generated reads.
Because no significant matches were found, off-target mapping is de facto absent. Therefore, the artificial SIRV sequences are suitable for non-interfering qualitative and quantitative assessments in known genomic systems, and they are complementary to the ERCC sequences. 
PRODUCTION OF SIRV MIXES
The SIRVs were produced by in vitro transcription (IVT) from linearized plasmids, yielding SIRV RNAs of high purity but varying integrity. Since the SIRV transcripts represent isoforms with overlapping sequences, break-down products of SIRV RNAs can potentially affect the detection and quantification of other isoforms. Therefore, a set of tailored purification procedures was applied to obtain full-length RNAs with a minimal amount of side products despite the broad sequence and length variation of the SIRVs ( Fig. 2A) . By capillary electrophoresis (Bioanalyzer, Agilent) the purified SIRV RNAs were assessed to be at least to 90.31±3.72 % of correct length. Each SIRV transcript entered the final mixes via one of eight PreMixes, allowing for the unique identification of each SIRV by capillary electrophoresis (Fig. 2B ). The PreMixes were merged pairwise in equal amounts to yield four SubMixes, which were then combined in defined volumetric ratios to create the final mixes. The experimentally determined cumulative pipetting error for individual SIRVs is smaller than ±8 %, while the applied SubMix scheme limits the maximum error for differential gene expression experiments to only ±4 %. Bioanalyzer traces were used to monitor the relative propagation of the SIRVs in Pre-and SubMixes during the staged mixing (Fig. 2B) . The mix E0 maintains equimolar SIRV concentration ratios; E1 contains a maximum concentration difference of 8-fold (close to one order of magnitude); and E2 comprises a concentration difference of up to 128-fold. The inter-mix concentration ratios range from 1/64-to 16-fold (Fig. 2C ). Three different samples with SIRVs, RC-0, RC-1 and RC-2 (for details see methods section), were prepared, NGS libraries generated, and sequenced in paired-end 125 bp mode.
NGS DATA EVALUATION All demultiplexed NGS reads were mapped to the human genome (GRCh38.p2), the ERCC sequences and the SIRVome by using the common splice-aware aligners STAR (Dobin et al. 2012) , TopHat2 (Kim et al. 2013) , while Bowtie2 (Langmead and Salzberg 2012) was used to map reads to a set of accordingly generated transcript sequences. Bowtie2 aligned reads were further processed by RSEM (Li and Dewey 2011) , a combination referred to below as data evaluation pipeline P1. Salmon is an autarkic program algorithm (Patro et al. 2015) , referred to as P2.
STAR as well as TopHat2 aligned reads were further processed by Cufflinks2 (Trapnell et al. 2012) , and resemble the evaluation pipelines P3, and P4.
ESTIMATION OF THE MRNA CONTENTS
On the basis of the assumption that the RNAs in the samples and the spike-in controls are equally targeted by the library preparation due to similar length distributions ( ̅ SIRV 1·129±15 nt, ̅ ERCC 880±26 nt, and based on the P4 results ̅ UHRR 1·538 nt, and ̅ HBRR 1·641 nt) the relative mass partition between controls and endogenous RNA can be determined. The propagation of the input amounts to the output read ratio depends on the mRNA content and the relative recovery efficiencies of controls and mRNA after the library preparation.
Therefore, one reference value needs to be defined or externally determined, which we chose to be 9 an mRNA content of 3 % in UHRR (Shippy et al. 2006) . We further set the efficiency of the endogenous mRNA proceeding through this particular library preparation to 100 %. The SIRVs can then be calculated to progress with a relative efficiency of 87.0±6 %, allowing to determine the mRNA content in the second sample, HBRR, to be 1.72 %. The mRNA content in the mixed samples RC-2 is then assessed to be 2.34 % which corresponds to a minor -9.1 % offset relative to the theoretical outcome based on the RC-0 and RC-1 measurements. Fig. 3 shows for one example, gene SIRV 3 in E0, the expected coverages and counts of the telling junctions together with the coverages obtained by STAR and TopHat2 mapping. NGS workflow-specific read start-site distributions lead to coverage patterns with inherent terminal deficiencies for which the expected coverage has been adjusted accordingly. However, in the measured coverages these systematic start-and end-site biases are accompanied by a variety of biases which introduce severe local deviations from the expected coverage. To obtain a comparative measure, gene-specific coefficients of deviation, CoD, were calculated. CoDs describe the often hidden biases in the sequence data predominantly caused by an inhomogeneous library preparation, but also by the subsequent sequencing and mapping. In the presented example, the stranded TruSeq library preparation with the Illumina HiSeq2500 sequencing and mapping by The CoD does not allow to distinguish between periodicity and randomness in the biases nor does it forecast how well a data evaluation strategy can cope with the bias contributions.
Nevertheless, smaller CoD values are expected to correlate with a simpler and less error-prone data evaluation. The CoD values can be taken as a first, indicative measure to characterize the mapped data, and to compare data sets for similarity up to this point in the workflow. Target-performance comparisons of all SIRV genes in all three mixes can be found in the supplemental information.
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The above described four data analysis pipelines, P1 to P4, were used to calculate transcript gives the lowest value with 1.29, followed by P4 with 1.64, P1 with 1.98, and P2 with 2.14. However, a sample-specific global target-performance comparison is not the strongest criteria for evaluating performance differences at transcript resolution. For this purpose the apparent differential expression shows if similar errors are caused by the same or different transcripts. The highest concordance was found between P3 and P1 (labelled P3/P1) calculated as standard deviation of all SIRV LFCs with 1.01, followed by P4/P3 (1.04), P4/P1 (2.55), P2/P1 (2.88), and P3/P2 (3.09). The lowest concordance has P4/P2 with a value of 4.12. One section of the resulting heat map for both extremes is shown in Tab. 1C. The same pipeline comparisons were made with either all endogenous transcripts, or the ones in the higher SIRV expression range and compared to the pipeline concordances calculated with the SIRV controls (Fig. 5) . We define the first bin with |LFC| < 1 as the bin of no apparently differentially expressed transcripts independent of the corresponding p-values. The other bins contain transcripts for which the calculated concentrations differ by more than 2-fold, hence convene apparently differentially expressed transcripts (DE). We find that SIRV controls and endogenous transcripts are evaluated coherently. While theoretically no differences are expected, pipelines P3 and P1 differ in their quantification of the same data by 4.4 % for the SIRVs, and by 6.9 % for endogenous RNAs in the SIRV concentration range (Fig. 5A ). Pipelines P2 and P4 differ to a larger extent when evaluating the same samples (Fig. 5B, C) . The same correlation is seen in comparisons between different samples (shown here for RC-0 vs. RC-1). The expected DE between reference RNAs UHRR and HBRR of approximately 50 % is evaluated differently by P3 vs. P1 (DE of 2.4 %), and this is mirrored in the evaluation of the SIRV mixes spiked into these reference RNAs (DE of 4.9 %). P4 vs. P2 performed worse with a pipeline difference of 3.9 % and 10.3 % for endogenous and SIRV transcripts. The controls show a highly similar increase when comparing P3/P1 with P4/P2 (2.1-fold from 4.9 % to 10.3 %) to the endogenous RNAs (1.6-fold from 2.4 % to 3.9 %). Here, the average measurement using the same pipeline provide a pseudo-ground truth, which is compared to the measurement using different pipelines. It allows to quantify the additional error caused solely by changes in the pipeline. A change from pipeline P3 to P1 would increase the number of DE-detected transcripts to a smaller extent than a change from P2 to P4, and this is true for both, the SIRV controls and the endogenous transcripts. 
Reads from SIRV mixes E0, E1, and E2 were processed by four different data evaluation algorithms for transcript quantification. Results derived by pipeline P3 are exemplarily shown in reference to the known inputs (bars in colors corresponding to the SIRV SubMixes of Fig. 2). The black circles mark
METHODS
SIRV DESIGN AND IN SILICO ANALYSIS
The gene structures of seven human model genes (KLK5, LDHD, LGALS17A, DAPK3, HAUS5, USF2, and TESK2) were used as scaffold for the design of SIRV1 to SIRV7. The ENCODE-annotated transcripts as well as added variants were edited to represent in a redundant and comprehensive manner known transcription and alternative splicing variations (complete gene structures are shown in the odd-numbered suppl. Fig. from S3 to S15). All exon sequences descend from a pool of database-derived genomes (gene fragments from viruses and bacteriophage capsid proteins and glycoproteins selected based on a GC-content in a range of 30-50%) which were modified by inverting the sequence to lose identity while maintaining a kind of naturally occurring order in the sequences. Intron sequences that do not align with exons of another isoform were drawn from random sequences whereby the GC content was balanced to comply with the adjacent exonic sequences (Random DNA Sequence Generator, http://www.faculty.ucr.edu/~mmaduro/random.htm).
To verify the sequence exclusivity, first, the exon sequences were blasted against the entire NCBI all SIRVs in "no significant similarity found". Second, in silico generated reads (Griebel t al. 2012) (FLUX-Generator, http://sammeth.net/confluence/display/SIM/Home, command line: /flux-simulator -p ~/…/Flux/sirv1.par -t simulator -x -l -s) were mapped to nine individually selected genomes using TopHat2 (Kim et al. 2013 ) and Bowtie2 (Langmead and Salzberg2012) . Because Bowtie2-aligned reads can be as short as 20 nt, the resulting limited number of mapping reads would be deemed to 
SIRV CONSTRUCTS AND THE PRODUCTION OF IN-VITRO TRANSCRIPTS Synthetic gene constructs
were produced (Bio Basic Inc, Markham, ON, Canada) that comprised 5' to 3' a unique restriction site, a T7 RNA polymerase promoter whose 3' G is the first nucleotide of the actual SIRV sequence, which is seamlessly followed by a (A30)-tail that is fused with an exclusive 2 nd restriction site. These gene cassettes were cloned into a vector, colony-amplified and singularized. All SIRV sequence in the purified plasmids were verified by Sanger-sequencing to identify the correct clones. The E. coli cultures were grown in batches to obtain plasmids in the lower µg-scale. Double digestion of isolated plasmids with XhoI and NsiI showed correct insert size and complete restriction. Linearized, silicapurified plasmids served as templates in in vitro transcription reactions using T7 transcription kits (AmpliScribe T7 High Yield Transcription Kit, and AmpliScribe T7 Flash Transcription Kit, Epicentre,
Madison, WI). The DNase-treated, phenol-extracted and silica-purified in vitro transcription products
were assessed for concentration and purity by spectrophotometry (NanoDrop, Thermo Fisher Scientific, Waltham, MA) and for integrity by capillary electrophoresis (2100 Bioanalyzer, RNA 6000
Pico Kit, Agilent Technologies, Santa Clara, CA).
In the context of variant verification RNA integrity is a very important measure. Fragments arising from incomplete transcription might impose errors on the correct determination of variants which share those sequences and thereby also affect the overall gene coverage. The integrity of the transcription products was very heterogeneous as expected, given the broad sequence variation and the length of the SIRV transcripts (average 1.1 kb with 14 RNAs between 2.0 and 2.5 kb). A majority of transcripts therefore had to be purified by at least one of two purification methods. Purification method PP1 is selective for poly(A)-tails and neglects prematurely terminated transcription products.
Purification method PP2 is based on size-selective quantitative electrophoresis separating the correctly sized main products from shorter fragments (transcription break off and degraded products) and longer fragments (run-through transcription products). After purification, the 69 SIRV RNAs were assessed to be on average 7.36±3.43 % in the pre-peak fraction, 90.31±3.72 % in the main-peak fraction (corresponding to RNAs of correct length), and 2.36±3.04 % in the post-peak fraction (mass percentages, wt%). Noteworthy, the risks of a beginning degradation during the initial denaturation (2 min at 70°C) and the not fully denaturing conditions during RNA microcapillary electrophoresis, tiny noise levels in the baseline, and slightly different shapes of the main peak result in a rather over-than underestimation of pre-and post-peak fractions. SIRV MIXING SIRV mixes were designed that contain pools of SIRVs (SubMixes) in defined amounts and ratios by combining accurate volumes of the stock solutions in sufficiently large batch sizes. Pipetting errors vary depending on transfer volumes, and range from ±4 % for 2 µl to ±0.8 % for >100 µl transfers. The precision was experimentally determined with blank solutions. Starting with the stock concentration measurement (NanoDrop accuracy ±2 ng/µl for 50 ng/µl, or ±4 %), and accounting for the entire mixing pathway, the accumulative concentration error is expected to range between ±8 % and ±4.7 %. Therefore, in the data evaluation one has to account for the experimental fuzziness by allowing for lower accuracy thresholds of ±8 % on the linear scale, or ±0.11 on the log2-fold scale, respectively. The SIRV concentration ratios between two mixes are more precise because only one final pipetting step defines the concentration differences and synchronizes all SIRVs, which belong to the same SubMix. Here, a maximal error of ±4 % (or ±0.057 on the log2-fold scale) can be expected between SubMixes, while all SIRVs of the same SubMix must propagate coherently into the final mixes. Bioanalyzer traces were used to monitor the relative propagation of the SIRVs, PreMixes and SubMixes during the mixing (Fig. 2B ). In addition, the accurate pipetting of the 8 PreMixes was controlled by checksums of Nanodrop concentration measurements which deviated by only 0.002±3.4 % from the calculated target concentrations, and by weighing on an analytical balance, which showed a deviation of 1.8±0.65 %. The final concentration of the SIRV mixes are set to be 25.3 ng/µl.
SPIKING OF REFERENCE RNA WITH SIRV MIXES
In general, SIRV mixes can be used with crude cell extracts, purified total RNA, rRNA-depleted RNA or poly(A)-enriched RNA. Important, the spike-in ratios have to be chosen in concordance with the desired final SIRV content, the RNA preparation method and, if known, the expected mRNA content. One widely applicable spike-in ratio can be obtained by adding 0.06 ng of controls to approximately 100 ng of total RNA. In the presented examples, the total RNA mass of one single aliquot RNA was 100 ng of UHRR in RC-0, and 112.8 ng of HBRR in RC-1. The reference RNA in RC-2 was calculated to be 104.27 ng (Fig. S2) . The high- mRNA proceed through the library preparation. The relationship is described by Eqn. 1.
Equation 1 with r, number of reads; from eRNA, the endogenous RNA fraction, here mRNA, and con, the controls, here SIRVs and ERCC; E, the relative efficiency of how the fraction proceeds through the workflow; and m, the input mass.
Ratios are measured as relative read counts, and the results as a product of efficiencies and apparent amounts are also relative measures. Therefore, at least one de facto arbitrary reference point needs to be defined to deduce comparable, absolute results. Several reference points or default values can be defined which lead to different dependent variables, and imply slightly variable interpretation of the results. The following three calculation examples are simple deductions from the ratio shown in Eqn. 1 with the ERCC (con,1), and the SIRVs (con,2) respectively. Variation 1 is explained in greater detail, while in the other variants only the differing aspects are highlighted. ii) The relative amounts of reads which have been assigned to either endogenous mRNA, ERCCs, or SIRVs are obtained from the mapping statistics (read classification).
iii) The ratio of mass input to reads output allows to calculate the propagation efficiency of the controls relative to the default efficiency of the endogenous mRNA. In the present experiment, The observed small differences in the experiments using RC-0, RC-1, or RC-2 could be caused by a two-way interference of samples and controls. However, the deviations are small and can rather be a result of minor inaccuracies in determining the relative input amounts. Both hypotheses would need to be verified by a series of repeats with the aim to resolve potential influences of pipetting during the sample preparation, variations in the library preparation, and other contributions.
Variation 2
Here, no varying interferences between samples and controls are permitted which means that relative efficiencies of the controls are considered to be constant. The causes of the experimental variations are exclusively assigned to the input amounts (alike hypothesis two in the above example in discussing the deviation of the results in RC-2). This would translate into input standard deviations of 11.8 % (SIRVs) and 7.6 % (ERCCs). The variations meld all accumulating errors made in determining the concentration of the control stock solutions, preparing the subsequent dilutions, pipetting the samples and controls during the spike-in step itself, as well as determining the amount of sample RNA in the first place. Against the background of potential errors the calculated results can be considered as highly consistent.
Variation 3
In addition to the assumptions made for the measurement of sample RC-0 the spike-in of 0.06 ng SIRVs to all samples is also set as default. Alike variation 2 the experiments in RC-1, and RC-2, adopt the same default setting for the relative efficiencies calculated in RC-0.
According to the ratio of Eqn. 1 one can obtain mRNA contents as well as ERCC input amounts, in this case for samples RC-1, and RC-2. The mRNA content of the HBRR sample (RC-1) relative to the default mRNA content in the UHRR sample (set to 3 %) would be 1.72 %, lower than the previously assumed 2 %. According to the present mixing scheme it would also imply that sample RC-2 has an mRNA content of 2.54 %, up from the calculated 2.34 %. The offsets of -7.9 % is again small and very likely refers to the level of accuracy in the experimental results as discussed above. Using this method the spiking of samples with controls such as the SIRVs allows to closely estimate the relative mRNA content of any unknown sample, and to draw conclusions e.g. on the transcriptional state of tissues, cell suspension or individual cells.
COEFFICIENT OF DEVIATION
We implemented a strand specific Coefficient of Deviation In order to estimate expression values on transcript levels we applied RSEM (Li and Dewey 2011) which uses a Bayesian Network to compute the likelihood of each fragment belonging to a given transcript. Salmon (Patro et al. 2015) estimates the transcript expression values by a k-mer based mapping. Similar to RSEM, it uses an expectationmaximization (EM) algorithm to compute the maximum likelihood of relative abundances. Cufflinks2 estimates the transcript abundances with a coverage-based maximum likelihood approach. It determines the probability of read assignments to isoforms.
DIFFERENTIAL EXPRESSION ANALYSIS
We used the DESeq2 package (Love et al. 2014 ) for calculation of fold-differences between the results from different pipelines and different input samples mixtures. As explained in the main text, all outputs from the evaluated pipelines (in form of relative concentration measures) have been scaled. Scaling by linear transformation is needed as a consequence of the different mRNA contents in the samples but also to eventually compensate any potential pipetting errors when small aliquots, typically in the range of very few microliter, are added to individual samples. The RC-samples in this experiment were produced in a large batch to ensure high accuracy in volumetric ratios. The main sample pool is practically invariant to the small relative contribution of the controls but was technically treated in the same way by scaling the main sample pools to identical sizes. First, SIRV concentrations were scaled to reach together 69 in E0, 68.5 in E1, and 70.8 in E2, which is the dimensionless value identical to the fmol/µl in the respective SIRV stock solutions. Then, the lower threshold was set to 10 , ⅟7 th of one read for a 1 kb long transcript at a read depth of 30 Mio reads, or 1 gene specific read to be divided between 7 equally possible transcript variants at said 1 kb length section.
The threshold is to be understood as less than, or equal to, 10 -6 which defines an averaged read 30 resolution of the particular workflow at the given read depth. By these means all ratios remain defined.
Second, for the DESeq2 calculations we multiplied all values with 10 6 , after which fractions were rounded to the closest integer. We understand that for no-change hypothesis testing, which is the main purpose of the DESeq2 package, transforming the relative concentrations (FPKM or TPM) to 'quasi-read-counts' is not recommended, since DESeq2 internally corrects for library size by using size factors. However, in our application, we do not use the probability of the hypothesis rejection (P values) but the raw fold changes detected (irrespectively of the dispersion values for that given transcript). We also took into account the potential danger of censoring the input (by unintentionally eliminating transcripts represented by extremely low FPKM or TPM values) by setting a suitable threshold as described above. The figures show only two differential expression analyses because the 3rd concentration ratio, E2/E0, is the product of E1/E0 and E2/E1.
ERROR RATE ANALYSIS
The four red data points, two from the SIRV controls (circles) and two from the endogenous mRNAs (squares), from the best agreement (P3 vs, P1), and the four corresponding black data points from the worst agreement (P4 vs. P2) as shown in fig. 5E were fitted by linear approximation using the relationship as derived for Eqn. which has been used for the graph in fig. 5F . In the present context, the concept of ROC-curves is not applicable because the true or false negatives are indistinguishable as long the ground truth of the endogenous RNA are unknown.
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